Companion Animal Diagnostics Market Size, Share, Growth, and Industry Analysis, By Type (Clinical Biochemistry, Urinalysis, Immunodiagnostic, Hematology and Molecular Diagnostics), By Application (Clinical Pathology, Bacteriology and Parasitology), and Regional Insights and Forecast to 2034

•   
•   
  

  Download Free Sample to learn more about this report

    

COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW

The global companion animal diagnostics market size was USD 2.67 billion in 2025 and is projected to touch USD 5.65 billion by 2034, exhibiting a CAGR of 8.67% during the 2025–2034 forecast period.

Rising awareness among pet owners regarding animal health and the availability of advanced healthcare solutions with early disease detection and preventive care is driving the growth in companion animal diagnostics market. Increasing pet adoption, in particular dogs and cats, is bolstering demand for precise diagnostic tests that facilitate early treatment of infectious disease metabolic disorders, and chronic illnesses. Veterinary clinics and animal hospitals are now implementing new diagnostic technology such as immunodiagnostics, molecular diagnostics, hematology analyzers and imaging systems to provide better patient care. This growing focus on pet health, coupled with an increasing spend on veterinary services is set to transform the industry and place a greater emphasis on diagnostic accuracy, workflow efficiency and greater patient outcomes. Furthermore, the growing trend of pet humanization has led to the polarization of health screening, with identification of potential health risks being faster and long-term care getting increasingly better. The expansion in diagnostic applications is steadily positioning the market as a vital pillar within the overall veterinary ecosystem.

Additionally, the market is supported by the technological developments such as portable point-of-care devices, AI-based imaging tools, robotic laboratory analyzers that ease and expedite veterinary diagnostics. Telemedicine integration and digital pathology are also emerging enabling veterinarians to perform remote consults and collaborate with specialized labs in real-time. Rising incidence of zoonotic diseases has increased demand for accurate diagnostic solutions to ensure animal and human health. Additionally, pharmaceutical and biotechnology firms are focusing on advanced diagnostic platforms for better disease surveillance and more effective therapeutic applications. Collaborative ventures are raising the capacity to test between veterinary clinics and manufacturer of diagnostics, also research organizations extend these capabilities further into both metropolitan and rural areas. Personalisation of pet care, preventive wellness and fast diagnostic turnaround are growing focus areas, which is expected to keep the companion animal diagnostics market on path of continued growth, bolstered by innovation, accessibility, and changing consumer expectations.

COVID-19 IMPACT

Companion Animal Diagnostics Industry Had a Negative Effect Due to supply chain disruption during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The impact of COVID-19 on companion animal diagnostics market was both positive and negative, it brought some challenges and growth opportunity in this market. During the first lockdown veterinary clinics saw fewer visits and were forced to reschedule appointments and temporarily halt services, slowing down routine diagnostic testing. Availability of diagnostic consumables and instruments was also affected by supply-chain disruptions in several countries. But as the crisis dragged on, pet adoptions skyrocketed as people craved company during isolation, leading to a surge in demand for veterinary services and diagnostics. This transformation led to a period of rapid growth in tele-veterinary services and remote diagnostic sessions, allowing veterinarians to deliver consistent care. Moreover, increased knowledge related to zoonotic diseases further intensified the focus on early testing, disease monitoring and preventive diagnostics. Therefore, the market witnessed an impact of pandemic to restrain its growth initially but, it displaced the market towards growth in the long-run from increased pet ownership, digital transformation and focus on proactive animal health management.

LATEST TRENDS

Rise of Point-of-Care and AI-Enhanced Diagnostics in Companion Animal Health to Drive Market Growth

A key trend impacting the market for companion animal diagnostics is the increasing use of point-of-care (POC) testing instruments, which allow veterinarians to conduct diagnostics in real time in clinics. These handheld instruments provide rapid results for routine chemistry panels, hematology assays, infectious disease testing, and electrolyte analysis, facilitating clinical workflow and informing immediate patient care. Another major trend includes the development of artificial intelligence (AI) in imaging diagnosis including radiology, ultrasound and digital pathology. AI-powered software can identify anomalies with higher accuracy and in less time and assist veterinarians in multi-faceted diagnostic cases. In addition, there is an increased focus on molecular diagnostics in the market, particularly PCR-based assays with high sensitivity for detection of emerging infectious diseases. Increasing pet humanization is also contributing to demand for routine wellness examinations and preventive diagnostics, bringing veterinary care from reactive treatment to proactive monitoring. The development of tele-veterinary services and VC-connected diagnostic devices are also conducive to augmenting data sharing, remote consultations, and integrated patient management, all of which solidify digital-enabled diagnostics as an instrumental growth catalyst in the industry.

•   
•   
  

  Download Free Sample to learn more about this report

    

COMPANION ANIMAL DIAGNOSTICS MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into clinical biochemistry, urinalysis, immunodiagnostic, hematology and molecular diagnostics

• Clinical Biochemistry: Clinical biochemistry testing is an assessment of metabolic activity, organ integrity, and biochemical indices in pet animals. These include tests that enable identification of kidney diseases, liver diseases, diabetes, and hormone-related diseases. They are extensively utilized for routine wellness exams and pre-surgical screenings.

• Urinalysis: Urinalysis plays an important role in determining health of the urinary tract, kidney, and metabolism. Veterinarians use it to detect infections, dehydration, and crystals or abnormal metabolites. The test is easy to conduct, quick, and is often part of the routine examination.

• Immunodiagnostic: Immunological assays are used to identify the presence of infectious diseases, allergens, and elicited immune response based on ELISA, lateral flow test and rapid test kits. They are excellent in terms of sensitivity and the earliest detection of the most common canine and feline diseases. These tests enable preventative care and focused treatment protocols.

• Hematology: Hematology tests blood cell counts and shape to diagnose anemia, infections, inflammation, and coagulation disorders. High-quality results can be obtained rapidly from automated analyzers to facilitate emergency and routine care. Hematology is vital in the diagnosis of various systemic diseases.

• Molecular Diagnostics: Molecular diagnostics such as PCR and nucleic acid tests can be used to detect pathogens with high specificity and sensitivity. They are essential for the identification of emerging infectious diseases and genetically predisposed disorders. These instruments increase disease monitoring and facilitate early intervention.

By Application

Based on application, the global market can be categorized into clinical pathology, bacteriology and parasitology

• Clinical Pathology: The clinical pathologist evaluates body fluids and tissues and certain biochemical and cellular markers in the peripheral blood to diagnose diseases of the body. It facilitates a full evaluation of health and well-being and aids in treatment decisions. Many veterinary hospitals and diagnostic laboratories have this application.

• Bacteriology: Bacteriology is the identification of bacterial infections of the skin, respiratory, digestive, and urinary systems. Cultures can also detect sensitivity tests, which can assist veterinarians in determining which antibiotics will be appropriate to use. It is critical to infectious disease treatment and to the control of antimicrobial resistance.

• Parasitology: Parasitology Identifies internal and external parasites through stool testing, blood work and imaging. It is used in the diagnosis of diseases caused by worms, mites and protozoan. This application promotes the preventive approach to patient care and the development of efficient parasite control programs.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Rising Pet Humanization and Expanding Veterinary Healthcare Spending to Boost the Market

A primary contributor to the companion animal diagnostics market growth is the increasing trend of pet humanization which has transformed the global pet care market. Pet owners are treating dogs, cats and other companion animals as family members more so than ever before. This emotional change has a direct impact on the spending, which is now tipping towards more spending on preventive care and routine wellness testing, and early detection of diseases. As awareness is raised by veterinary campaigns about the need for such diagnoses, owners are more inclined to pay for better healthcare solutions. Increasing access to sophisticated clinical biochemistry, immunodiagnostic, and molecular techniques contributes to this trend by allowing for quicker and more accurate information to be obtained. Furthermore, increasing disposable income in developing countries and growing veterinary infrastructure facilitate increasing veterinary visitation. The increasing longevity of companion animals through better nutrition and care, creates a rising demand for diagnostic tests to manage age-related diseases which will drive the demand for the market across veterinary settings globally.

Increasing Burden of Zoonotic, Infectious, and Chronic Diseases in Companion Animals to Expand the Market

The increasing incidences of zoonotic, infectious and chronic diseases within pets is also a key factor promoting growth of the companion animal diagnostics market. Diseases, like tick-borne diseases, renal failure, diabetes, and gastrointestinal infections, need to be monitored and diagnosed accurately, requiring veterinarians to utilize sophisticated hematology, urinalysis, and molecular diagnostic systems. As public health concerns increase, the regulatory authority emphasizes the need for an early disease detection to minimize the risk of zoonotic transmission, more so in pet-prone localities. The rising interaction between human and companion animal is leading to an increasing demand for consistent diagnostic screening. Veterinary hospitals and reference labs are also expanding their testing capabilities for more diseases and with quicker turnaround times, leading to more confident treatment decisions. Increasing climatic variations lead to the prevalence of vector-borne diseases, further fueling the demand for high-sensitive testing products. In general, these health effects drive the development and global adoption of advanced companion animal diagnostic solutions.

Restraining Factor

High Diagnostic Costs to Potentially Impede Market Growth

A major restraining factor for the companion animal diagnostics market is the expensive nature of sophisticated diagnostic tests and instruments. Several molecular diagnostics and immunoassays, as well as automated hematology analyzers, require substantial investments, which prevent many small veterinary clinics or pet owners with modest financial means from acquiring them. In a number of underdeveloped and cost-sensitive countries, the owners of pets tend to accept basic treatments instead of diagnostic confirmation, affecting sophisticated testing services. Furthermore, maintenance costs, skilled technicians, and calibration at regular intervals add to the operational costs of a veterinary clinic. In many parts of the world, insurance coverage for companion animals is still relatively uncommon and the cost of diagnostic services for animals go mostly out-of-pocket. This disparity in continued care accessibility leads to gaps in early disease screening and preventive care even as knowledge levels are growing. The cost hurdle also limits the uptake of advanced point-of-care technologies that could make diagnostic processes more efficient. As a result, cost-related issues continue to hamper growth of the overall companion animal diagnostics market.

Growing Scope for Point-of-Care Diagnostic Integration in Veterinary Clinics To Create Opportunity for the Product in the Market

Opportunity

The pet animal diagnostics market offers a significant opportunity, owing to growing adoption of point of care testing solutions by veterinary clinics and pet hospital. Veterinarians are placing greater importance on a faster diagnosis and treatment decisions, which is increasing the sales of portable analyzers and hand-held instruments that provide results quickly and reliably without having to send samples to a centralized laboratory. This transition helps to improve clinical efficiency and pet care quality in general, especially for acute or chronic conditions that demand close, timely monitoring.

In addition, new developments in microfluidics, biosensors, and miniaturized immunoassay platforms are driving point-of-care technologies to be more accurate, cost effective, and flexible, leading to an even wider adoption. Increasing pet ownership and rising demands for human-style medical care for animals continue to contribute to the need for easy-to-use diagnostic tools, indicating point-of-care scaling as a potential path for long-term growth. This opportunity is further enhanced by the growing collaboration between veterinary clinics and diagnostic technology companies, to optimize workflows and speed up diagnostic turnaround.

Shortage of Skilled Veterinary Laboratory Professionals Could Be a Potential Challenge for Consumers

Challenge

Human skilled veterinary laboratory staff capable of utilizing high end testing technologies to work in the companion animal diagnostics sector continues to be a challenge to find. With increasing complexity of diagnostic platforms, staff working in clinics and laboratories need training in molecular assays, haematology systems, immunodiagnostics and understanding of test results. Nevertheless, the number of such trained personnel is extremely limited, particularly in developing countries where veterinary education and laboratory system is still in infant stages. This shortage in qualified talent may decrease the diagnostic efficiency, cause delayed results, and prevent the infiltration of more complex detailed instruments, which require professional knowledge on calibration, maintenance, and interpretation.

In addition, many smaller clinics do not have the funds to employ full-time diagnostic technicians, which only continues to deepen disparities in access to quality testing. The intricacies of novel diagnostic solutions, coupled with a lack of trained operators, create practical challenges in delivering services, or expanding into new markets. This persistent limitation highlights the demand for enhanced training and uniform skill development in veterinary diagnostics.

•   
•   
  Download Free Sample to learn more about this report

    

COMPANION ANIMAL DIAGNOSTICS MARKET REGIONAL INSIGHTS

• North America

North America is expected to contribute maximum revenue in the global companion animal diagnostics market, owing to high pet ownership rates, sophisticated veterinary service, and a large number of pet owners that are aware of preventive health screening. United States companion animal diagnostics market growth is driven by high expenditure on pet wellness, increasing awareness for early detection of diseases, and rapid adoption of digital testing platforms. The use of molecular panels, immunodiagnostic assays, and real-time point-of-care devices is on the rise in veterinary organisms and reference laboratories throughout the country, adding to the more pervasive market penetration. Furthermore, the region’s long-term market growth is attributed to relentless product development, robust distribution channels and a growing number of insured pets.

• Europe

Europe exhibits steady progress in the companion animal diagnostics market share, primarily supported by structured veterinary regulations, strong clinical infrastructure, and rising demand for advanced diagnostics. The region benefits from increasing awareness of zoonotic disease prevention, which encourages veterinarians to adopt tools delivering improved companion animal diagnostics market share. Countries across Western Europe show high acceptance of molecular and hematology testing, while Central and Eastern Europe are gradually upgrading laboratory capabilities. The region’s market trajectory is reinforced by growing collaborations between veterinary clinics and diagnostic solution providers.

• Asia

Asia demonstrates substantial growth potential, driven by expanding pet adoption, urbanization, and rising expenditure on animal healthcare. The region’s companion animal diagnostics market share strengthens as countries invest in veterinary hospitals, modern laboratories, and portable diagnostic systems suitable for diverse environments. Rapid modernization in countries such as China, India, and South Korea is improving access to high-quality diagnostic tools, while awareness campaigns are increasing the use of preventive and routine screening. Continuous investments from global manufacturers and rising veterinary education standards are further enhancing the region’s long-term diagnostic landscape.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Leading companies in the companion animal diagnostics market are focusing on strengthening their portfolios through continuous innovation, strategic collaborations, and expanded global distribution capabilities. Many players are investing in advanced molecular platforms, AI-integrated diagnostic tools, and rapid point-of-care systems to improve accuracy, turnaround time, and clinical decision-making. Companies are also enhancing their R&D pipelines to introduce multiplex assays, automated hematology solutions, and more sensitive immunodiagnostic tests suited for early disease detection. Alongside technology development, firms are increasing veterinarian training initiatives, partnering with clinics and reference laboratories, and expanding manufacturing facilities to meet rising demand across both developed and emerging markets. Sustainability, data security, and seamless integration with veterinary practice management software are also becoming core focus areas as industry leaders aim to deliver more connected and efficient diagnostic ecosystems.

List Of Top Companion Animal Diagnostics Companies

• IDEXX Laboratories (United States)
• Zoetis (United States)
• Thermo Fisher Scientific (United States)
• Virbac (France)
• Heska Corporation (United States)
• Neogen Corporation (United States)
• bioMérieux SA (France)
• IDvet (France)
• INDICAL Bioscience GmbH (Germany)
• Randox Laboratories (United Kingdom)

KEY INDUSTRY DEVELOPMENT

February 2024: IDEXX Laboratories (United States) announced the launch of an upgraded molecular diagnostic panel designed to enhance the early detection of infectious diseases in companion animals. The new panel integrates advanced PCR technology with improved workflow automation, enabling veterinarians to deliver faster and more accurate diagnostic results. The development also includes expanded test coverage for emerging pathogens, addressing the growing need for comprehensive screening in clinical settings. By strengthening efficiency and diagnostic precision, this launch supports veterinary clinics and reference laboratories in improving disease management, preventive care, and overall diagnostic outcomes.

REPORT COVERAGE

This report offers a comprehensive examination of the companion animal diagnostics market, providing detailed insights into key segments, including clinical biochemistry, immunodiagnostics, hematology, urinalysis, and molecular diagnostics, as well as major applications such as clinical pathology, bacteriology, and parasitology. It evaluates market dynamics through an in-depth analysis of driving factors, restraining elements, opportunities, and challenges shaping industry growth. The study further highlights evolving consumer behavior, technological advancements, regulatory frameworks, and emerging trends influencing diagnostic adoption across various regions.

The report also assesses regional developments with a structured focus on North America, Europe, and Asia, offering clarity on regional competitiveness and shifts in market share. It includes strategic evaluations of leading industry players, outlining their product enhancements, innovation efforts, and global expansion strategies. Additionally, the report provides recent industrial developments with month-specific updates, ensuring readers gain a real-time understanding of market progress. Together, these elements present a robust foundation for stakeholders to make informed strategic decisions.